Académique Documents
Professionnel Documents
Culture Documents
What is Dementia? What is the difference in Delerium vs Dementia? Delerium superimposed on dementia What is Alzheimers Disease?
http://www.alzheimers.org/rmedia/adanimation.htm
Is it Alzheimers? Ten Warning Signs of Alzheimers Disease Alzheimers vs. normal age-related memory changes
http://www.youtube.com/watch?v=7wbYE K7O14E
Alzheimers Statistics A person with Alzheimers Disease will live an average of eight years and as many as 20 years or more from the onset of symptoms. Alzheimers Disease is the 6th leading cause of death in the US. 6 million Americans currently have the disease. Women are more likely than men to develop Alzheimers. 16 million Americans will have Alzheimers Disease by 2050 unless a cure is found. The cost of diagnosing and caring for people with Alzheimers Disease currently stands at $14.8 million.
Communication
The person with Alzheimers Disease will exhibit changes in his/her usual pattern of expressing him/herself. Communication changes progress and ability decreases as the disease progresses. The person who is in communication with a person who has Alzheimers disease must remember that patience is a virtue!! Do not dispute unless safety issue.
Challenging Behaviors
Assessment of the behavior
i.e. repetitive actions, wandering
Evaluate
is the repetitive action decreased if that is the goal?
Are other interventions needed?
Assisting the person who has Alzheimers Disease with personal care
Bathing Dressing Grooming - Toileting - Dental Care - Eating
Implications for acute care environment Person-centered care in long term care
Caregiver Issues
Feelings of inadequacy/ feeling overwhelmed Withdraw from family, friends, activities Worry that the person with Alzheimers is safe Anxiety about money and healthcare decisions Denial of the impact of the disease and its effects on the family as a whole Grief or sadness that relationship has changed Frustration/anger toward the person with Alzheimers Health problems of their own
Alzheimers Association (2008)
Cholinergics (Parasympathomimetics)
Slow the breakdown of acetylcholine Effective in mild to moderate Alzheimers VERY expensive
NMDA Antagonist
Namenda
N-methyl D-aspartate antagonist Believed to regulate glutamate in the brain Delays progression of some symptoms in moderate to severe Alzheimers Can be prescribed in combination with cholinesterase inhibitors i.e. Exelon + Namenda Aricept + Namenda
Other Medications
Anti-depressants Tranquilizers for severe agitation Anti-oxidants such as Vit.E, antiinflammatories, and estrogen replacement therapy in women are all currently being studied
Creative Storytelling Timeslips method creative expression for people with dementia through storytelling
www.timeslips.org
Pain Management and Alzheimers Disease ASPMN (2008) Is pain always subjective? Pain behaviors to watch for Pain assessment tools Alzheimers Disease in the acute care setting (Allen & Close, 2010) NICHE Model
Current Evidence
NHS www.nurseshealthstudy.org
Insulin Levels and Memory
(Okereke et al., 2006)
Stay tuned
Proton magnetic resonance spectroscopy can identify early changes in brain chemistry linked to AD prior to cognitive deficits (Kantarci et al., 2011
311 subjects in their 70s and 80s